Concepts (77)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholelithiasis | 1 | 2024 | 10 | 0.920 |
Why?
|
| Cholecystectomy | 1 | 2024 | 15 | 0.920 |
Why?
|
| Ambulatory Care Facilities | 1 | 2024 | 51 | 0.900 |
Why?
|
| Emergency Service, Hospital | 2 | 2024 | 117 | 0.880 |
Why?
|
| Hospital Costs | 1 | 2018 | 29 | 0.620 |
Why?
|
| Health Expenditures | 1 | 2018 | 29 | 0.620 |
Why?
|
| Medically Uninsured | 1 | 2018 | 30 | 0.620 |
Why?
|
| Length of Stay | 2 | 2019 | 215 | 0.620 |
Why?
|
| Spinal Cord Injuries | 1 | 2018 | 55 | 0.600 |
Why?
|
| Wounds and Injuries | 4 | 2024 | 166 | 0.540 |
Why?
|
| Patient Discharge | 2 | 2024 | 97 | 0.400 |
Why?
|
| Venous Thromboembolism | 2 | 2024 | 133 | 0.360 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2020 | 46 | 0.330 |
Why?
|
| Retrospective Studies | 5 | 2024 | 2454 | 0.320 |
Why?
|
| Adult | 7 | 2024 | 7492 | 0.260 |
Why?
|
| Middle Aged | 6 | 2024 | 6900 | 0.250 |
Why?
|
| Clinical Protocols | 2 | 2024 | 45 | 0.250 |
Why?
|
| Aged | 4 | 2024 | 5222 | 0.240 |
Why?
|
| Trauma Centers | 3 | 2022 | 114 | 0.230 |
Why?
|
| Ultrasonography | 1 | 2024 | 229 | 0.210 |
Why?
|
| Anticoagulants | 1 | 2024 | 293 | 0.190 |
Why?
|
| Female | 7 | 2024 | 14636 | 0.190 |
Why?
|
| Male | 6 | 2024 | 13022 | 0.190 |
Why?
|
| Immunization, Secondary | 1 | 2020 | 10 | 0.180 |
Why?
|
| Vaccination Coverage | 1 | 2020 | 11 | 0.180 |
Why?
|
| Splenectomy | 1 | 2020 | 43 | 0.180 |
Why?
|
| General Surgery | 1 | 2021 | 53 | 0.180 |
Why?
|
| Delayed Diagnosis | 1 | 2020 | 18 | 0.180 |
Why?
|
| Heart Injuries | 1 | 2020 | 8 | 0.180 |
Why?
|
| Postoperative Care | 1 | 2020 | 67 | 0.170 |
Why?
|
| Patient Compliance | 1 | 2020 | 75 | 0.170 |
Why?
|
| Spleen | 1 | 2020 | 109 | 0.170 |
Why?
|
| Humans | 10 | 2024 | 27121 | 0.170 |
Why?
|
| Adolescent | 4 | 2022 | 2988 | 0.170 |
Why?
|
| Conservative Treatment | 1 | 2019 | 10 | 0.170 |
Why?
|
| Foreign Bodies | 1 | 2019 | 16 | 0.170 |
Why?
|
| Rectum | 1 | 2019 | 50 | 0.170 |
Why?
|
| Vancomycin | 1 | 2019 | 56 | 0.160 |
Why?
|
| Surgical Procedures, Operative | 1 | 2019 | 46 | 0.160 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 36 | 0.160 |
Why?
|
| Heart Atria | 1 | 2020 | 171 | 0.160 |
Why?
|
| Telemedicine | 1 | 2022 | 164 | 0.160 |
Why?
|
| Staphylococcal Infections | 1 | 2019 | 81 | 0.160 |
Why?
|
| Insurance Coverage | 1 | 2018 | 31 | 0.150 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 171 | 0.150 |
Why?
|
| Internship and Residency | 1 | 2021 | 228 | 0.150 |
Why?
|
| Linear Models | 1 | 2018 | 201 | 0.150 |
Why?
|
| Young Adult | 3 | 2020 | 2626 | 0.140 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 1940 | 0.140 |
Why?
|
| Postoperative Complications | 1 | 2020 | 605 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 497 | 0.120 |
Why?
|
| Oklahoma | 1 | 2018 | 978 | 0.120 |
Why?
|
| Societies, Medical | 2 | 2024 | 89 | 0.100 |
Why?
|
| United States | 3 | 2024 | 2060 | 0.100 |
Why?
|
| Injury Severity Score | 2 | 2019 | 117 | 0.080 |
Why?
|
| Pulmonary Embolism | 1 | 2024 | 126 | 0.050 |
Why?
|
| Patient Transfer | 1 | 2022 | 42 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2024 | 595 | 0.050 |
Why?
|
| Meningitis | 1 | 2020 | 11 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2021 | 103 | 0.040 |
Why?
|
| Rupture | 1 | 2020 | 11 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2021 | 125 | 0.040 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2020 | 43 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2020 | 162 | 0.040 |
Why?
|
| Sepsis | 1 | 2020 | 81 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2021 | 216 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2019 | 99 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2019 | 46 | 0.040 |
Why?
|
| Curriculum | 1 | 2021 | 271 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 218 | 0.040 |
Why?
|
| Critical Illness | 1 | 2019 | 66 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2019 | 91 | 0.040 |
Why?
|
| Risk Factors | 1 | 2024 | 2030 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2022 | 1219 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 234 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 988 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2019 | 2283 | 0.030 |
Why?
|